Live Breaking News & Updates on Professor Karen Geboes

Stay updated with breaking news from Professor karen geboes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with Cetuximab

SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with CetuximabBASEL, Switzerland, January 19, 2023 / B3C newswire / SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced today that the first patient was dosed in its Phase 2 AURELIO-05 combi. ....

Region Flamande , Richard Sachse , Karen Geboes , Eric Van Cutsem , University Hospital In Leuven Belgium , Gent University Hospital Belgium , Department Of Gastrointestinal , First Patient , Nanrilkefusp Alfa , Gent University Hospital , Professor Karen Geboes , Digestive Oncology , University Hospital ,

SOTIO Biotech: SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with Cetuximab

BASEL, Jan. 19, 2023, a clinical stage immuno-oncology company owned by PPF Group, announced today that the first patient was dosed in its Phase 2 AURELIO-05 combination trial of nanrilkefusp alfa ....

Region Flamande , Kostenloser Wertpapierhandel , Richard Sachse , Karen Geboes , Eric Van Cutsem , Michael Tattory , Richard Kapsa , University Hospital In Leuven Belgium , Gent University Hospital Belgium , Lifesci Communications , Department Of Gastrointestinal , Superagonist Technology , Gent University Hospital , Professor Karen Geboes , Digestive Oncology , University Hospital ,